Stock, CJW;
Bray, WG;
Kouranos, V;
Jacob, J;
Kokosi, M;
George, PM;
Chua, F;
... Renzoni, EA; + view all
(2023)
Serum C-reactive protein is associated with earlier mortality across different interstitial lung diseases.
Respirology
10.1111/resp.14609.
(In press).
Preview |
PDF
Serum C reactive protein is associated with earlier mortality.pdf - Published Version Download (531kB) | Preview |
Abstract
Background and Objective: The acute-phase protein C-reactive protein (CRP) is known to be associated with poor outcomes in cancer and cardiovascular disease, but there is limited evidence of its prognostic implications in interstitial lung diseases (ILDs). We therefore set out to test whether baseline serum CRP levels are associated with mortality in four different ILDs. Methods: In this retrospective study, clinically measured CRP levels, as well as baseline demographics and lung function measures, were collected for ILD patients first presenting to the Royal Brompton Hospital between January 2010 and December 2019. Cox regression analysis was used to determine the relationship with 5-year mortality. Results: Patients included in the study were: idiopathic pulmonary fibrosis (IPF) n = 422, fibrotic hypersensitivity pneumonitis (fHP) n = 233, rheumatoid arthritis associated ILD (RA-ILD) n = 111 and Systemic Sclerosis associated ILD (SSc-ILD) n = 86. Patients with a recent history of infection were excluded. Higher CRP levels were associated with shorter 5-year survival in all four disease groups on both univariable analyses, and after adjusting for age, gender, smoking history, immunosuppressive therapy and baseline disease severity (IPF: HR (95% CI): 1.3 (1.1–1.5), p = 0.003, fHP: 1.5 (1.2–1.9), p = 0.001, RA-ILD: 1.4 (1.1–1.84), p = 0.01 and SSc-ILD: 2.7 (1.6–4.5), p < 0.001). Conclusion: Higher CRP levels are independently associated with reduced 5-year survival in IPF, fHP, RA-ILD and SSc-ILD.
| Type: | Article |
|---|---|
| Title: | Serum C-reactive protein is associated with earlier mortality across different interstitial lung diseases |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1111/resp.14609 |
| Publisher version: | https://doi.org/10.1111/resp.14609 |
| Language: | English |
| Additional information: | This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third-party material in this article are included in the Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| Keywords: | C-reactive protein, CRP, fHP, fibrotic hypersensitivity pneumonitis, idiopathic pulmonary fibrosis, ILD, interstitial lung disease, IPF, RA-ILD, rheumatoid arthritis associated ILD, SSc-ILD, systemic sclerosis associated ILD |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Respiratory Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10179163 |
Archive Staff Only
 |
View Item |
